Treace Medical Concepts, Inc.

Treace Medical Concepts, Inc.

TMCI·NASDAQ

$3.56

+4.6%
HealthcareMedical - Devices

Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as for MTP fusion. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra Beach, Florida.

At a Glance

Live Snapshot
Market Cap$230.62M
EPS-0.9300
P/E Ratio-3.82
Earnings Date08/06/2026

tmci

Long Term Debt

Last Annual Value

13.98M

3-Year CAGR

-36%

5-Year CAGR

-14%

10-Year CAGR

-3%

Treace Medical Concepts, Inc.

Treace Medical Concepts, Inc. Competitors Analysis of Long Term Debt

TMCI · NASDAQ
CompanyLong Term Debt
CAGR 3Y
CAGR 5Y
CAGR 10Y
13.98M
-35.9%-13.8%N/A 
RXST logo
RxSight, Inc.
NASDAQ:RXST
9.88M
N/A-24.3%N/A
BVS logo
Bioventus Inc.
NASDAQ:BVS
278.95M
-8.7%-3.9%N/A
EHAB logo
Enhabit, Inc.
NYSE:EHAB
423.70M
-7.2%161.0%N/A
0.00
N/AN/AN/A
645.00K
N/AN/AN/A
NPCE logo
NeuroPace, Inc.
NASDAQ:NPCE
68.72M
6.5%6.6%N/A
EOLS logo
Evolus, Inc.
NASDAQ:EOLS
146.10M
6.7%15.5%N/A
35.59M
-4.8%-9.9%8.9%
299.00K
-57.8%-65.8%-47.7%
99.82M
116.0%45.7%19.1%
Treace Medical Concepts, Inc.

Treace Medical Concepts, Inc. Fair Value Envelope

TMCI · NASDAQ

Our analysis suggests that TMCI has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $3.555, this represents a potential HIDDEN relative to our calculated worth for Treace Medical Concepts, Inc..

Intrinsic Value
Current Price: $3.555